Medicis (MRX) Announces New Patents for SOLODYN 90mg
Tweet Send to a Friend
Medicis (NYSE: MRX) today announced that the United States Patent and Trademark Office (USPTO) has advised the Company that U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


